Expression of activated platelet‐derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Platelet‐derived growth factor receptor (PDGF‐R) expression has been reported in a variety of cancers, including colorectal, breast, lung, ovarian and pancreatic cancers, but the role of PDGF‐R expression in the development and progression of colon carcinoma has not yet been elucidated. The purpose of this study was to examine the expression of PDGF and PDGF‐R in human colon carcinomas. The expression of PDGF, PDGF‐R and phosphorylated PDGF‐R (p‐PDGF‐R) was examined by immunofluorescence in 12 surgical specimens of colon carcinoma and in human colon carcinoma cells growing in the subcutis (ectopic site) and the cecal wall (orthotopic site) of nude mice. In most surgical specimens, tumor cells expressed PDGF‐A and ‐B subunits, without corresponding levels of PDGF‐Rα and PDGF‐Rβ. PDGF‐Rβ was predominantly expressed by tumor‐associated stromal cells and pericytes of tumor vasculature. The expression of PDGF‐Rβ in the stroma was associated with advanced stage disease. Under culture conditions, human colon carcinoma cell lines expressed PDGF‐A and ‐B, but not PDGF‐R. In orthotopic tumors, the KM12 cells (Duke's stage B) expressed PDGF‐A and ‐B, but PDGF‐Rβ was expressed only by stromal cells and pericytes in the tumor vasculature. This expression of PDGF‐Rβ by stromal cells and pericytes was higher in tumors growing at the orthotopic site than in those at the ectopic site. The expression of PDGF‐Rβ in the stroma was higher in highly metastatic KM12SM tumors than in low metastatic KM12C tumors. In conclusion, the expression of PDGF‐Rβ in stromal cells is influenced by the organ‐specific microenvironment and is associated with metastatic potential. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Ebert, M., Yokoyama, M., Friess, H., Kobrin, M. S., Büchler, M. W., & Korc, M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620507 · Cited by 125
Janat, M. F., & Liau, G. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041500203 · Cited by 66
Cited by
Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H. (2015) · Cancers · doi:10.3390/cancers7040902 · Cited by 774
Targeting the PDGF signaling pathway in tumor treatment
Heldin, C.-H. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-97 · Cited by 540
Mesenchymal stem cells enhance growth and metastasis of colon cancer
Shinagawa, K., Kitadai, Y., Tanaka, M., Sumida, T., Kodama, M., Higashi, Y., Tanaka, S., Yasui, W., & Chayama, K. (2010) · International Journal of Cancer · doi:10.1002/ijc.25440 · Cited by 308
Self-citationInvolvement of platelet‐derived growth factor ligands and receptors in tumorigenesis
Heldin, C. ‐., Lennartsson, J., & Westermark, B. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12690 · Cited by 181
Expression of cancer-associated fibroblast markers in advanced colorectal cancer
Nishishita, R., Morohashi, S., Seino, H., Wu, Y., Yoshizawa, T., Haga, T., Saito, K., Hakamada, K., Fukuda, S., & Kijima, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8097 · Cited by 59
Metadata
- Authors
- Kitadai, Y., Sasaki, T., Kuwai, T., Nakamura, T., Bucana, C. D., Hamilton, S. R., & Fidler, I. J.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2006-10-20
- Volume
- 119
- Issue
- 11
- Pages
- 2567-2574
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2092041940
- Cited by
- 95
- References
- 4
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.